{"acute myocardial infarction": 8.14, "anaphylactic reaction": 3.01, "anti factor vii antibody positive": 5258.24, "cardiac arrest": 6.81, "cardiac ventricular thrombosis": 35.04, "cerebral haemorrhage": 4.09, "cerebral infarction": 18.79, "cerebral ischaemia": 40.35, "cerebrovascular accident": 3.67, "concomitant disease progression": 990.81, "death": 8.74, "deep vein thrombosis": 17.26, "disseminated intravascular coagulation": 55.96, "drug ineffective": 5.89, "drug ineffective for unapproved indication": 12.25, "embolism": 25.55, "exsanguination": 1220.59, "haemarthrosis": 35.28, "haematoma": 6.85, "haematuria": 6.84, "haemorrhage": 16.87, "haemorrhage intracranial": 17.83, "intestinal ischaemia": 38.06, "ischaemic stroke": 9.83, "multiple organ dysfunction syndrome": 46.75, "myocardial infarction": 5.35, "off label use": 5.38, "peripheral artery thrombosis": 107.88, "peripheral ischaemia": 51.09, "portal vein thrombosis": 24.32, "post procedural haemorrhage": 18.55, "pulmonary embolism": 13.42, "sepsis": 7.1, "septic shock": 5.26, "shock haemorrhagic": 57.27, "therapeutic response decreased": 49.13, "thrombosis": 9.74, "thrombotic stroke": 162.45, "vena cava thrombosis": 103.11, "venous thrombosis": 22.11, "venous thrombosis limb": 16.69}